SCHEMBL436856

SCHEMBL436856

NOCc1csc(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL958545 0.81
SCHEMBL6363647 0.81
Hydrochloric Acid SCHEMBL4780449 0.79 RAB9A (0.60)
SCHEMBL1556938 0.78
SCHEMBL15512235 0.78 IDO1 (0.63)
SCHEMBL4873752 0.78 RAB9A (0.54)
SCHEMBL4400464 0.78 MAPT (0.53)
SCHEMBL3600443 0.77 SMN1; SMN2 (0.50)
SCHEMBL403275 0.77
SCHEMBL19080596 0.76 SMN1; SMN2 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022040110-A2 ALKYLATING AGENT AND COMBINATIONS IN THE TREATMENT OF IMMUNE-RELATED AND LIVER DISEASES, ALZHEIMER'S DISEASES AND FIBROSIS DISEASES LIU SHENG (US) 2022-02-24 WO claimed
US-10722530-B2 Methods of diagnosing and treating cancer CASE WESTERN RESERVE UNIVERSITY (US) 2020-07-28 US claimed
US-10725042-B2 Methods of diagnosing and treating cancer CASE WESTERN RESERVE UNIVERSITY (US) 2020-07-28 US claimed
US-20180185403-A1 METHODS OF DIAGNOSING AND TREATING CANCER CASE WESTERN RESERVE UNIVERSITY 2018-07-05 US claimed
US-20170071965-A1 ANTIMETABOLITE AGENT COMBINATIONS IN THE TREATMENT OF CANCER UNIV CASE WESTERN RESERVE (US) 2017-03-16 US claimed
US-9498489-B2 Antimetabolite agent combinations in the treatment of cancer CASE WESTERN RESERVE UNIVERSITY (US) 2016-11-22 US claimed
US-8716346-B2 Alkylating agent combinations in the treatment of cancer CASE WESTERN RESERVE UNIVERSITY (US) 2014-05-06 US claimed
US-20140066464-A1 METHODS OF DIAGNOSING AND TREATING CANCER CASE WESTERN RESERVE UNIVERSITY (US) 2014-03-06 US claimed
US-8324282-B2 Alkylating agent combinations in the treatment of cancer CASE WESTERN RESERVE UNIVERSITY (US) 2012-12-04 US claimed
US-20120065145-A1 ALKYLATING AGENT COMBINATIONS IN THE TREATMENT OF CANCER GERSON STANTON L (US) 2012-03-15 US claimed
US-20100267657-A1 ANTIMETABOLITE AGENT COMBINATIONS IN THE TREATMENT OF CANCER CASE WESTERN RESERVE UNIVERSITY 2010-10-21 US claimed
US-5849768-A α-unsaturated amines, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-12-15 US claimed
EP-0529680-B1 Intermediates, their production and their use for preparing alpha-unsaturated amines TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-05-13 EP claimed
EP-0302389-B1 Alpha-unsaturated amines, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1993-12-22 EP claimed
EP-0529680-A2 Intermediates, their production and their use for preparing alpha-unsaturated amines TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-03-03 EP claimed
WO-2022040110-A2 ALKYLATING AGENT AND COMBINATIONS IN THE TREATMENT OF IMMUNE-RELATED AND LIVER DISEASES, ALZHEIMER'S DISEASES AND FIBROSIS DISEASES LIU SHENG (US) 2022-02-24 WO disclosed
US-10722530-B2 Methods of diagnosing and treating cancer CASE WESTERN RESERVE UNIVERSITY (US) 2020-07-28 US disclosed
US-4914206-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-04-03 US disclosed
EP-0302389-A2 Alpha-unsaturated amines, their production and use Takeda Chemical Industries, Ltd. (JP) 1989-02-08 EP disclosed
EP-0226896-A2 Lankacidin derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1987-07-01 EP disclosed